Belem, W.F.; Liu, C.-H.; Hu, Y.-T.; Burnouf, T.; Lin, L.-T.
Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viruses 2022, 14, 2419.
https://doi.org/10.3390/v14112419
AMA Style
Belem WF, Liu C-H, Hu Y-T, Burnouf T, Lin L-T.
Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viruses. 2022; 14(11):2419.
https://doi.org/10.3390/v14112419
Chicago/Turabian Style
Belem, Wendimi Fatimata, Ching-Hsuan Liu, Yee-Tung Hu, Thierry Burnouf, and Liang-Tzung Lin.
2022. "Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)" Viruses 14, no. 11: 2419.
https://doi.org/10.3390/v14112419
APA Style
Belem, W. F., Liu, C.-H., Hu, Y.-T., Burnouf, T., & Lin, L.-T.
(2022). Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viruses, 14(11), 2419.
https://doi.org/10.3390/v14112419